OTCMKTS:LCDX Caliber Imaging & Diagnostics (LCDX) Stock Price, News & Analysis $0.0006 0.00 (0.00%) As of 05/29/2026 11:00 AM Eastern Add Compare Share Share Stock Analysis Stock AnalysisChartShort InterestBuy This Stock About Caliber Imaging & Diagnostics Stock (OTCMKTS:LCDX) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get LCDX alerts:Sign Up Key Stats Today's Range$0.0006▼$0.000650-Day Range N/A52-Week Range$0.00▼$0.05Volume8,254 shsAverage Volume11,647 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview Caliber Imaging & Diagnostics, Inc. is a medical technology company focused on developing advanced imaging solutions that quantify trace elemental composition in human tissue. The firm’s core technology leverages spectral analysis methods adapted from mass spectrometry to deliver non-invasive, point-of-care measurements of bone health and related physiological parameters. By translating elemental imaging into a clinical setting, Caliber Imaging aims to enhance disease screening and monitoring for conditions such as osteoporosis and other metabolic bone disorders. The company’s flagship product line features compact imaging devices designed to integrate into hospital and outpatient environments. These systems employ patented ionization and detection techniques to provide rapid, quantitative data on elements such as calcium and potassium within bone or soft tissue. Caliber Imaging’s platform offers clinicians an alternative to conventional radiographic densitometry by supplying elemental concentration maps that can improve diagnostic accuracy and support personalized treatment plans. Originally established as Astrotech Analytical, Caliber Imaging & Diagnostics emerged following a strategic shift from space and environmental instrumentation to healthcare applications. The enterprise is headquartered in The Woodlands, Texas, and maintains research collaborations with academic and clinical institutions across North America. Caliber Imaging’s management team combines expertise in analytical chemistry, biomedical engineering, and regulatory affairs to guide the company through development, validation, and commercialization phases.AI Generated. May Contain Errors. Read More Receive LCDX Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Caliber Imaging & Diagnostics and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. LCDX Stock News HeadlinesCaliber Imaging & Diagnostic (LCDX) Gets a Hold from Morgan StanleyOctober 8, 2025 | theglobeandmail.comCaliber Imaging & Diagnostic (LCDX) Gets a Hold from Cantor FitzgeraldOctober 8, 2025 | theglobeandmail.comGoldman Sachs just told you what to buy (most people missed it)Goldman Sachs just revealed that 40% of AI data centers will be crippled by electricity shortages by 2027 - not chips, not funding, but power. Demand is growing 15% per year and the grid can't keep up. One small company makes the exact equipment these data centers need. They're sitting on $1.5 billion in orders, their hardware is already inside Musk's Colossus, and the stock still trades like a name nobody's heard of. Analyst Dylan Jovine is releasing the ticker for free. | Behind the Markets (Ad)Stifel Nicolaus Sticks to Its Buy Rating for Caliber Imaging & Diagnostic (LCDX)February 28, 2025 | markets.businessinsider.comLCDX Caliber Imaging & Diagnostics, Inc.February 27, 2025 | seekingalpha.comCaliber Imaging & Diagnostic (LCDX) was downgraded to a Sell Rating at Bank of America SecuritiesFebruary 26, 2025 | markets.businessinsider.comCaliber Imaging & Diagnostics IncDecember 29, 2024 | morningstar.comMCaliber Imaging & Diagnostics, Inc. (LCDX)February 9, 2024 | nz.finance.yahoo.comSee More Headlines LCDX Stock Analysis - Frequently Asked Questions How have LCDX shares performed this year? Caliber Imaging & Diagnostics' stock was trading at $0.0006 on January 1st, 2026. Since then, LCDX stock has increased by 0.0% and is now trading at $0.0006. How do I buy shares of Caliber Imaging & Diagnostics? Shares of LCDX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Caliber Imaging & Diagnostics own? Based on aggregate information from My MarketBeat watchlists, some other companies that Caliber Imaging & Diagnostics investors own include NIO (NIO), Tesla (TSLA), Costco Wholesale (COST), NVIDIA (NVDA) and Advanced Micro Devices (AMD). Industry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry Medical Devices Sub-IndustryMedical Equipment Current SymbolOTCMKTS:LCDX CIKN/A Webwww.caliberid.com Phone585-239-9800FaxN/AEmployees28Year FoundedN/AProfitability EPS (Trailing Twelve Months)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A 7 Stocks to Buy And Hold ForeverClick the link to see MarketBeat's list of seven stocks and why their long-term outlooks are very promising. Get This Free Report This page (OTCMKTS:LCDX) was last updated on 5/31/2026 by MarketBeat.com Staff. From Our PartnersThe 1934 playbookIn 1934, a legal government maneuver transferred billions in wealth overnight. Most Americans never saw it com...American Alternative | Sponsored$30 stock to buy before Starlink goes public (WATCH NOW!)In the next 3 minutes… James Altucher – legendary investor and venture capitalist… And someone who’s kno...Paradigm Press | SponsoredTrump's gold order: the announcement they won't put on the front pageOn August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...Reagan Gold Group | SponsoredYour book attachedYour Download Link (Expiring) If you still haven't downloaded the free Simple Options Trading For Beginners...Profits Run | SponsoredMy feud with Zohran MamdaniEmmy-winning analyst releases his next big story Whitney Tilson shocked the nation on 60 Minutes when he ac...Stansberry Research | SponsoredSpaceX just filed. The clock is ticking.Reuters reports Elon Musk filed secretly. Barron's says it's being finalized behind closed doors. CNBC just re...The Oxford Club | SponsoredRead now. Do not delete. You’ve been warned.Three Nobel Prize Winners expose this once-in-a-generation wealth shift: “Don’t Say I Didn’t Warn You” P...Porter & Company | SponsoredSpaceX will mint billionaires. You won't be one of them.By the time a company goes public, 95% of profits have already been made. Insiders bought SpaceX at $20 billio...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Caliber Imaging & Diagnostics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Caliber Imaging & Diagnostics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.